Alembic Pharmaceuticals informs about press release

23 Nov 2021 Evaluate

Alembic Pharmaceuticals has informed that it enclosed a press release regarding receipt of US Food & Drug Administration (USFDA) Tentative Approval for Dabigatran Etexilate Capsules, 150 mg.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

770.85 7.95 (1.04%)
23-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1732.20
Dr. Reddys Lab 1307.00
Cipla 1326.10
Zydus Lifesciences 907.90
Lupin 2245.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×